(19)
(11) EP 1 631 264 B8

(12) CORRECTED NEW EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B2)

(48) Corrigendum issued on:
24.05.2017 Bulletin 2017/21

(45) Date of publication and mentionof the opposition decision:
08.03.2017 Bulletin 2017/10

(45) Mention of the grant of the patent:
29.07.2009 Bulletin 2009/31

(21) Application number: 04776195.2

(22) Date of filing: 02.06.2004
(51) International Patent Classification (IPC): 
A61K 9/50(2006.01)
A61K 9/02(2006.01)
A61K 39/12(2006.01)
 A61K 9/16(2006.01)
A61K 9/08(2006.01)
(86) International application number:
PCT/US2004/017125
(87) International publication number:
WO 2005/020964 (10.03.2005 Gazette 2005/10)

(54)

IMMUNOGENIC COMPOSITIONS BASED ON MICROPARTICLES COMPRISING ADSORBED TOXOID AND A POLYSACCHARIDE-CONTAINING ANTIGEN

IMMUNOGENE, AUF MIKROPARTIKEL BASIERENDE ZUSAMMENSETZUNGEN, DIE AUS EINEM ADSORBIERTEN TOXOID UND EINEM POLYSACCHARID ENTHALTENDEN ANTIGEN BESTEHEN

COMPOSITIONS IMMUNOGENES BASEES SUR DES MICROPARTICULES BIODEGRADABLES COMPRENANT DES ANATOXINES DIPHTHERIQUES ET TETANIQUES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 02.06.2003 US 475010 P
21.10.2003 US 513074 P

(43) Date of publication of application:
08.03.2006 Bulletin 2006/10

(60) Divisional application:
09075251.0 / 2179729

(73) Proprietor: GlaxoSmithKline Biologicals SA
1330 Rixensart (BE)

(72) Inventors:
  • O'HAGAN, Derek
    Emeryville, CA 94608 (US)
  • SINGH, Manmohan
    Emeryville, CA 94608 (US)
  • KAZZAZ, Jina
    Emeryville, CA 94608 (US)

(74) Representative: Chapman, Desmond Mark et al
Carpmaels & Ransford LLP One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
WO-A-02/26209
US-A- 6 007 845
 US-A- 5 981 719
US-A1- 2002 136 776
   
  • PEYRE-M. SESARDIC-D. MERKLE-H-P, GANDER-B, JOHANSEN-P.: "Divalent Microsphere Vaccines Are Protective Against Tetanus and Diphtheria" PROCEED. IN'L. SYMP. CONTROL. REL. BIOACT. MATER., vol. 28, 2001, pages 1077-1078, XP009042702
  • I. JABBAL-GILL ET AL.: 'Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines' VACCINE vol. 18, 2000, pages 238 - 350